Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00552474 · ClinicalTrials.gov registry record · NA
Deep Brain Stimulation to Treat Symptoms of Parkinson's Disease
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 136
- Enrollment target
NCT00552474 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 136 participants.
The verdict
NCT00552474, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 136 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of bilateral stimulation of the subthalamic nucleus (STN) of the brain when using the ANS Totally Implantable Deep Brain Stimulation System as an adjunctive treatment for reducing some of the symptoms of Parkinson's Disease that are not adequately controlled with medication.
Interventions
- DEVICE Libra Deep Brain Stimulation System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2005-10 |
| Est. Completion | 2016-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00552474
The ClinicalTrials.gov registry entry for NCT00552474 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Libra Deep Brain Stimulation System is the first listed.
NCT00552474 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00552474 about?
NCT00552474 is a clinical study titled "Deep Brain Stimulation to Treat Symptoms of Parkinson's Disease". The purpose of this study is to evaluate the safety and efficacy of bilateral stimulation of the subthalamic nucleus (STN) of the brain when using the ANS Totally Implantable Deep Brain Stimulation System as an adjunctive treatment for reducing some of the symptoms of Parkinson's Disease that are no...
What is the current status of trial NCT00552474?
This trial is currently completed. It is a NA study. The enrollment target is 136 participants. The study started on 2005-10. Estimated completion is 2016-11.
What interventions are being tested in trial NCT00552474?
The interventions under investigation include: Libra Deep Brain Stimulation System (DEVICE).
Who is sponsoring clinical trial NCT00552474?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.